Haemonetics Corp
SWB:HAZ
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
64.5
88.5
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Haemonetics Corp
Haemonetics Corp
Revenue
Haemonetics Corp
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Haemonetics Corp
NYSE:HAE
|
Revenue
$1.4B
|
CAGR 3-Years
13%
|
CAGR 5-Years
7%
|
CAGR 10-Years
4%
|
|
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
Revenue
$3.9B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
0%
|
CAGR 10-Years
3%
|
|
|
ICU Medical Inc
NASDAQ:ICUI
|
Revenue
$2.3B
|
CAGR 3-Years
22%
|
CAGR 5-Years
13%
|
CAGR 10-Years
23%
|
|
|
Align Technology Inc
NASDAQ:ALGN
|
Revenue
$4B
|
CAGR 3-Years
2%
|
CAGR 5-Years
12%
|
CAGR 10-Years
18%
|
|
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
Revenue
$1.5B
|
CAGR 3-Years
57%
|
CAGR 5-Years
34%
|
CAGR 10-Years
18%
|
|
|
Merit Medical Systems Inc
NASDAQ:MMSI
|
Revenue
$1.3B
|
CAGR 3-Years
8%
|
CAGR 5-Years
6%
|
CAGR 10-Years
10%
|
|
Haemonetics Corp
Revenue Breakdown
Breakdown by Geography
Haemonetics Corp
Breakdown by Segments
Haemonetics Corp
|
Total Revenue:
1.3B
USD
|
|
Business Unit:
1.3B
USD
|
|
Plasma Products And Services:
565.9m
USD
|
|
Hospital Products And Services:
445.4m
USD
|
|
Blood Center Products And Services:
276.1m
USD
|
|
Service:
21.6m
USD
|
Haemonetics Corp
Glance View
In the realm of healthcare, Haemonetics Corp. operates as a pivotal player, bridging the gap between innovation and life-saving technology. Founded in 1971, the company has evolved to become a leader in blood management solutions, riding the wave of advanced medical technology to cater primarily to hospitals and blood collection centers. At its core, Haemonetics specializes in products and software designed to optimize the collection, processing, and surgical use of blood. Among its notable contributions are devices for blood component separation and coagulation management systems, which play a critical role in ensuring that patients around the world receive safe and effective blood therapy. Revenue streams for Haemonetics come from a diverse range of blood management systems and services. Their offerings are not limited to physical products; the company also provides comprehensive software solutions that help institutions maximize efficiencies and improve patient outcomes. With a keen focus on research and development, Haemonetics continuously innovates to meet the stringent demands of the modern healthcare landscape. Their business model thrives on a combination of direct sales, strategic partnerships, and service agreements with hospitals and blood banks, all while maintaining a strong commitment to quality and regulatory compliance. Through its strategic approach, Haemonetics not only fulfills an essential healthcare need but also crafts a sustainable financial pathway by redefining how blood and related products are managed globally.
See Also
What is Haemonetics Corp's Revenue?
Revenue
1.4B
USD
Based on the financial report for Sep 28, 2024, Haemonetics Corp's Revenue amounts to 1.4B USD.
What is Haemonetics Corp's Revenue growth rate?
Revenue CAGR 10Y
4%
Over the last year, the Revenue growth was 10%. The average annual Revenue growth rates for Haemonetics Corp have been 13% over the past three years , 7% over the past five years , and 4% over the past ten years .
You don't have any saved screeners yet
